Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Cancer

Explore clinical trials studying Urinary Bladder Cancer. Study availability and eligibility vary by location and protocol.

30 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Cancer trial results

Completed

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

NCT03433924

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
  • Research Site Changsha, China
View all 17 locations
View Trial Details
Completed

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

NCT02722538

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

NCT02897765

Conditions
Bladder Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions